Items where authors include "Swinson, D."

Article

Baxter, M.A., Spender, L.C., Cairns, D. orcid.org/0000-0002-2338-0179 et al. (20 more authors) (2024) An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma. ESMO Open, 9 (5). 103450. ISSN 2059-7029

Robinson, O., Pini, S., Flemming, K. et al. (9 more authors) (2023) Exploration of pain assessment and management processes in oncology outpatient services with healthcare professionals: a qualitative study. BMJ Open, 13 (12). e078619. ISSN 2044-6055

Robinson, O.C. orcid.org/0000-0002-3171-4407, Pini, S., Flemming, K. et al. (9 more authors) (2023) Exploration of pain assessment and management processes in oncology outpatient services with healthcare professionals: a qualitative study. BMJ Open, 13 (12). e078619. e078619-e078619. ISSN 2044-6055

Ashley, L., Kassim, S., Kellar, I. et al. (8 more authors) (2022) Identifying ways to improve diabetes management during cancer treatments (INDICATE): protocol for a qualitative interview study with patients and clinicians. BMJ Open, 12 (2). e060402. ISSN 2044-6055

Gomes, F., Lewis, A., Morris, R. et al. (33 more authors) (2020) The care of older cancer patients in the United Kingdom. ecancermedicalscience, 14. 1101.

Monograph

Cree, A., Pearce, J., Battisti, N.M.L. et al. (12 more authors) (2023) Implementing frailty assessment and management in oncology services. Report. RCR national guidance documents . Royal College of Physicians and Royal College of Radiologists

Proceedings Paper

Pearce, J., Swinson, D., Cairns, D. orcid.org/0000-0002-2338-0179 et al. (6 more authors) (2021) SIOG2021-0064* - Frailty and treatment outcome in advanced gastro-oesophageal cancer: an exploratory analysis of the GO2 trial. In: Journal of Geriatric Oncology. SIOG 2021, 04-05 Nov 2021, Virtual. Elsevier , s35.

Preprint

West, E.J. orcid.org/0000-0001-7449-120X, Sadoun, A., Bendjama, K. et al. (21 more authors) (2024) A phase I clinical trial of intrahepatic artery delivery of TG6002 in combination with oral 5-fluorocytosine in patients with liver-dominant metastatic colorectal cancer. [Preprint]